Blood Biomarkers for Neurodegeneration

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

114 papers

Active filtersClassification:Core

Showing 13-24 of total 114 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

14-3-3γ Protects Against Postoperative Cognitive Dysfunction by Regulating Tau Thr205 Phosphorylation and Synaptic Integrity.

Zhu S; Han X; Zhang H; Ye C; Xia T; Gu X

2026PubMedDirectly related

Unbiased bioinformatic and clinical analysis identifies glial fibrillary acidic protein as a potential biomarker in spinal muscular atrophy.

Soares de Oliveira KL; Weber AC; Becker MM; Magalhães JSA; de Albuquerque ALA; Chadanowicz JK; Giudicelli GC; Rohden F; Zimmer ER; Kowalski TW; Siebert M; Costa MCM; Saute JA

Jan 1, 2026Brain communications

2026PubMedDirectly related

Epitope placement tunes CSF tau biomarkers: Comparison of P-tau217 and BD-tau designs.

Gleerup HS; Musaeus CS; Santos C; Kvartsberg H; Harrison P; Turton M; Zetterberg H; Frederiksen KS; Hasselbalch SG; Simonsen AH; Ortiz FG

Jan 1, 2026Molecular neurodegeneration advances

2026PubMedDirectly related

Neurofilament Light Chain (NfL) in Neurodegenerative Diseases: Biological and Clinical Significance, Multi-Omics Integration, and AI-Driven Biomarker Modeling for Precision Therapy.

Alshammari N; Hassan R; Patel M; Adnan M

Jan 1, 2026Pharmaceuticals (Basel, Switzerland)

2026PubMedDirectly related

Motor speech markers of Alzheimer's risk.

Giffard J; Bindoff AD; Roccati E; Li R; Vogel AP; Goldberg LR; Bai Q; King AE; Vickers JC; Alty J

Jan 1, 2026GeroScience

2026PubMedDirectly related

Comparative Analysis of Plasma Biomarkers of Alzheimer's Disease and Frontotemporal Dementia: The Dual Role of Soluble Fractalkine as a Biomarker of Frontotemporal Dementia and Its Neuroprotective Effects in Cortical Neurons "In Vitro".

Merino JJ; Rodríguez-Arellano JJ; Busquets X; Flores AI; Toledano A

Jan 1, 2026Life (Basel, Switzerland)

2026PubMedDirectly related

Comparative Analysis of Plasma Biomarkers of Alzheimer's Disease and Frontotemporal Dementia: The Dual Role of Soluble Fractalkine as a Biomarker of Frontotemporal Dementia and Its Neuroprotective Effects in Cortical Neurons "In Vitro".

Merino JJ; Rodríguez-Arellano JJ; Busquets X; Flores AI; Toledano A

Jan 1, 2026Life (Basel, Switzerland)

2026PubMedDirectly related

The Exposome-Brain Axis: A Scoping Review of Biological Biomarkers in Environmental Neurotoxicity, Neuroinflammation, and Neurodegeneration.

Curzio O; Donzelli G; Daoudagh S; Baldacci S; Bustaffa E; Cavigli C; Morales-Suárez-Varela M; Paradisi P; Moroni D; Minichilli F

Jan 1, 2026Toxics

2026PubMedDirectly related

Efficacy of Curcumin in Neurodegenerative Diseases: From Pharmacokinetic Barriers to Advanced Delivery Systems.

Castello-Guillen A; Garrido-Reig M; Caplliure-Llopis J; Vega-Bello MJ; Almela C; de la Rubia Ortí JE

Jan 1, 2026Pharmaceuticals (Basel, Switzerland)

2026PubMedDirectly related

Blood-based biomarkers in the anti-amyloid era of Alzheimer's disease: clinical utility, implementation challenges, and future directions.

Ho BL; Yang YH

Jan 1, 2026Neurodegenerative disease management

2026PubMedDirectly related

Dynamic changes in plasma biomarkers of Alzheimer's disease in patients treated with lecanemab: a longitudinal cohort study.

Mu R; Hofmann A; Gong K; Liu M; Roussak A; Lowery J; Chen Y; Paczynski M; Posey Z; Cheng Y; Xu Y; Xie Y; Powell WJB; Oh I; Gupta A; Sykora N; Budde J; Funk S; Benzinger TLS; Holtzman DM; Morris JC; Snider BJ; Bateman RJ; Schindler SE; Cruchaga C

Jan 1, 2026The Lancet. Neurology

2026PubMedDirectly related

Blood biomarkers of oxidative stress and mitochondrial dysfunction in Parkinson's disease and Alzheimer's disease.

Kumar D; Shee S; Datusalia AK; Sharma SS

Jan 1, 2026International review of neurobiology